News
Your Insights Are Shaping Know Your NETs 2026
More than 1,100 patients and caregivers from across the United States and internationally participated in NETRF’s 2026 Annual Patient and Caregiver Survey, sharing their experiences,
NETRF Research Round-Up: Two New Studies Illuminating NET Biology
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Two recent NETRF-funded studies are offering new insight into how neuroendocrine tumors grow, spread, and respond
A Duck Egg Model Offers a New Way to Study Neuroendocrine Tumors
At the Neuroendocrine Tumor Research Foundation (NETRF), we support research that can move the field forward, not only by advancing new treatments, but also by
New Data Offer Fresh Insights Into Life with Neuroendocrine Cancer
By Anna C. Greene, PhD, NETRF Chief Scientific Officer A new multi-institutional study provides one of the most comprehensive pictures to date of what life
From Professional to Personal: How Neuroendocrine Cancer Impacted a NETRF Research Grantee
Tijana Jovanovic-Talisman, PhD, is an Associate Professor at Beckman Research Institute at City of Hope and a 2025 NETRF Pilot Award grantee for her research
Mapping the Biology of Small Intestinal Neuroendocrine Tumors
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Scientists are discovering that where a tumor grows in the body may influence how it behaves.
How One Family is Moving Neuroendocrine Cancer Research Forward
For many families affected by neuroendocrine cancer, supporting research becomes a deeply personal mission. For Wayne Firsty and his children, Shay and Alana, that commitment
NETRF Clinical Trial Roundup: March 2026
Clinical Trials Highlight Advances in Neuroendocrine Tumor Research Research into neuroendocrine tumors (NETs) continues to progress, with clinical trials exploring both new treatment approaches and
ENETS 2026 Showcases Research Momentum and Spotlights NETRF-Funded Scientists
More than one thousand neuroendocrine cancer researchers, physicians, and patient advocates from over 50 countries gathered this month in Krakow, Poland, for the 23rd Annual
“Not Rare Anymore?” Why That Doesn’t Tell the Whole Story
By Anna C. Greene, PhD, NETRF Chief Scientific Officer In recent years, you may have seen headlines and commentaries suggesting that neuroendocrine cancers are “no